NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£20M
Sector
MISCELLANEOUS
Published
28 May 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 10 suppliers

1 buyer

10 suppliers

Description

NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. Offer reference number: CM/PHG/24/5716 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/24/5716/01– NHS National Framework for Lenalidomide, Pomalidomide & Thalidomide. CESW: (Midlands and Southwest): 1st June 2026 – 31st May 2028 NWLN: (Northwest and London North): 1st June 2026 – 31st May 2028 LSNE: (London South and Northeast): 1st June 2026 – 31st May 2028

Award Detail

1 Zentiva Pharma (Guildford)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
2 Viatris UK Healthcare (Hatfield)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
3 Teva (Castleford)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
4 Sun Pharma (Uxbridge)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
5 Wockhardt (Wrexham)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
6 Thornton & Ross (Huddersfield)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
7 Milpharm (South Ruislip)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
8 Lipomed (Weil am Rhein)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
9 Amarox (Harrow)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.
10 Accord (Barnstaple)
  • NHS National Generics Framework for Lenalidomide, Pomalidomide and Thalidomide
  • Reference: 1
  • Value: £19,595,208 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-051c39
  • FTS 050525-2026

Domains